About this trial
The purpose of this research is to examine the impact of peripheral neuropathy on fall risk and quality of life in people who had cancer and neuropathy from cancer treatments. The investigators are interested to find out if the participant have any difficulty with thinking, feeling, balancing, or moving around that will contribute to risk for falls or quality of life. Investigators are also interested to see if the participants have any difficulty with doing two activities at the same time, such as walking and texting.
Eligibility criteria
Qualifiers
Individuals 18 years and older
diagnosed with non- CNS cancer who underwent treatment and presents with peripheral neuropathy symptoms.
age (+/- one year) and gender matched individuals
no diagnosed peripheral neuropathy
Disqualifiers
Unable to follow two step commands.
Unable to ambulate x 50 feet independently without use of an assistive device.
Unable to use a phone to send text messages.
Diagnosis of diabetic peripheral neuropathy
Trial design
Treatments tested in this trial
- Not listed